Microdosing involves taking small, fractional, or sub-therapeutic doses that are used off-label to get potential benefits from the medication with minimal side effects
Access in the United States depends on regulatory status, clinical availability, insurance coverage, and the prescribed indication
This step ensures they are not using substandard, contaminated, or incorrect substances, such as the unapproved salt forms of semaglutide
Some patients experience temporary mood shifts during dose escalation, while others report improved emotional stability as weight loss reduces inflammation and improves sleep quality
A qualifying BMI or related health condition is typically required GLP-1 medications like semaglutide are usually prescribed to adults with a BMI over 30, or over 27 if they have a weight-related condition, such as high blood pressure, prediabetes, sleep apnea, or PCOS